The improvement of aqueous chemical stability of a model basic drug by ion pairing with acid groups of polyelectrolytes

Carbomer (C) and procaine (P) were selected respectively as models of polyelectrolyte (PE) and basic drug (B) of low stability in aqueous solution. The purpose of this investigation was to test if a (C–P) aqueous system provides a microenvironment in which P is less exposed to hydroxyl ion catalyzed...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 269; no. 1; pp. 149 - 156
Main Authors Jimenez-Kairuz, A.F., Allemandi, D.A., Manzo, R.H.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 09.01.2004
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Carbomer (C) and procaine (P) were selected respectively as models of polyelectrolyte (PE) and basic drug (B) of low stability in aqueous solution. The purpose of this investigation was to test if a (C–P) aqueous system provides a microenvironment in which P is less exposed to hydroxyl ion catalyzed degradation, its main degradation pathway over a wide pH range. It was determined that in (C–P) a high fraction of P was present in the form of ion pairs [RCOO −PH +] with the carboxylate groups of C. The [RCOO −PH +] fraction was above 97% for compositions containing higher than 50 mol% of P. The chemical stability of C–P was assayed at two selected pHs (7.5 and 8.5) in comparison with conventional reference solutions (RS) without C. Procaine in (C–P) was 4.2 and 6.2 times more stable than in its respective RS at the two conditions assayed. The stabilizing factor was calculated as the ratio of the rate constants k obs RS/ k obs C–P. Since C–B systems exhibit negative electrokinetic potential that attracts positive ions such as (H +) and repels negative ones such as (OH −), the stabilizing effect would be associated with the higher acidity of (C–P) environment, in which PH + molecules attached to the PE should also have lower kinetic energy than those in the bulk medium.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2003.09.008